INGN
Inogen, Inc.NASDAQHealthcareAs of 2026-04-06
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
0.88
P/S
0.48
EV/EBITDA
-20.18
DCF Value
$-6.24
FCF Yield
-12.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
47.6%
Operating Margin
-8.7%
Net Margin
-6.5%
ROE
-11.6%
ROA
-8.8%
ROIC
-12.3%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $81.7M | $-7.1M | $-0.26 |
| FY 2025 | $348.7M | $-22.7M | $-0.85 |
| Q3 2025 | $92.4M | $-5.3M | $-0.20 |
| Q2 2025 | $92.3M | $-4.2M | $-0.15 |
Analyst Ratings
View AllTrading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NASDAQ
Beta
1.71
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.